Please assess the completion status of the following clinical trial:

Trial Title: Overcoming Psychomotor Slowing in Psychosis (OCoPS-P)

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: TRIPLE
- Phase: None
- Number of Arms: 4.0

Eligibility Criteria:
Inclusion Criteria:~* Right-handed subjects~* Ability and willingness to participate in the study~* Ability to provide written informed consent~* Informed Consent as documented by signature~* Schizophrenia spectrum disorder according to diagnostic and statistical manual version 5 (DSM-5) criteria with current psychomotor slowing according to the Salpetriere Retardation Rating Scale (SRRS), score \>= 15~Exclusion Criteria:~* Substance abuse or dependence other than nicotine~* Past or current medical or neurological condition associated with impaired or aberrant movement, such as brain tumors, stroke, M. Parkinson, M. Huntington, dystonia, or severe head trauma with subsequent loss of consciousness.~* Epilepsy or other convulsions~* History of any hearing problems or ringing in the ears~* Standard exclusion criteria for MRI scanning and TMS; e.g. metal implants, claustrophobia~* Patients only: any TMS treatment in the past 3 months~* Women who are pregnant or breast feeding,~* Intention to become pregnant during the course of the study,~* Female participants who are surgically sterilised / hysterectomised or post-menopausal for longer than 2 years are not considered as being of child bearing potential.~* Previous enrolment into the current study,~* Enrolment of the investigator, his/her family members, employees and other dependent persons~* Controls only: history of any psychiatric disorder or first-degree relatives with schizophrenia spectrum disorders.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 60 Years
- Healthy Volunteers: t

Study Arms:
- Inhibitory repetitive transcranial magnetic stimulation (rTMS) (Type: EXPERIMENTAL): 1 Hz stimulation of 17 mins over the supplementary motor area (SMA), 1000 pulses at 110% resting motor threshold intensity total of 15 sessions in 3 weeks
- Facilitatory intermittent theta burst stimulation (iTBS) (Type: ACTIVE_COMPARATOR): Intermittent theta burst stimulation of 50 Hz over the supplementary motor area (SMA) with 600 pulses in 2 sec trains every 10 seconds for 190 seconds total. Two iTBS stimulations will be administered with 15 mins pause in between.~total of 15 sessions in 3 weeks
- Placebo (Type: PLACEBO_COMPARATOR): 1 Hz stimulation of 17 mins over the supplementary motor area (SMA) without any magnetic emission using a placebo-coil that looks identical and makes identical sounds as the real TMS coil total of 15 sessions in 3 weeks
- Waiting group (Type: NO_INTERVENTION): This group will receive no intervention for 3 weeks. Afterwards they will receive the inhibitory rTMS protocol as in the first arm

Based on this trial design, predict the completion outcome and termination type (if applicable).